UC Riverside has joined the University of California Drug Discovery Consortium, or UC DCC, "a cross-campus initiative aimed at building a drug discovery community that actively promotes research translation through industry partnerships."
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction and supports a mechanism critical for survival in mouse models of sepsis and colitis, according to a UC San Diego study.
The annual UC Riverside School of Medicine Faculty and Student Awards Banquet for 2019-20 was held online via Zoom on Wednesday, Oct. 14, 2020. The event, usually held with a celebratory banquet, was delayed due to the COVID-19 pandemic and eventually converted into an online event when it became clear…
Diverse teams across University of California San Diego, with collaborators elsewhere, have received two 5-year grants totaling $14.3 million from the National Institutes of Health (NIH) Common Fund to continue their work as a 4D Nucleome Research Hub and Center.
Health Media Contacts
Find the best contact for health-related media inquiries.
